These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25179207)

  • 1. Methodological developments in randomized controlled trial-based economic evaluations.
    Thorn JC; Noble SM; Hollingworth W
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):843-56. PubMed ID: 25179207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting.
    Petrou S; Gray A
    BMJ; 2011 Apr; 342():d1548. PubMed ID: 21474510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analysis conducted alongside randomized controlled trials: are economic end points considered in sample size calculations and does it matter?
    Hollingworth W; McKell-Redwood D; Hampson L; Metcalfe C
    Clin Trials; 2013 Feb; 10(1):43-53. PubMed ID: 23231969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.
    Dakin H; Gray A
    Stat Med; 2017 Aug; 36(18):2814-2830. PubMed ID: 28470760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
    Mugford M; Hutton G; Fox-Rushby J
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).
    Michaels JA; Campbell WB; Brazier JE; Macintyre JB; Palfreyman SJ; Ratcliffe J; Rigby K
    Health Technol Assess; 2006 Apr; 10(13):1-196, iii-iv. PubMed ID: 16707070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational therapy compared with social work assessment for older people. An economic evaluation alongside the CAMELOT randomised controlled trial.
    Flood C; Mugford M; Stewart S; Harvey I; Poland F; Lloyd-Smith W
    Age Ageing; 2005 Jan; 34(1):47-52. PubMed ID: 15537680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
    Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
    BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial factorial trials: comparing methods for statistical analysis and economic evaluation.
    Dakin HA; Gray AM; MacLennan GS; Morris RW; Murray DW
    Trials; 2018 Aug; 19(1):442. PubMed ID: 30115104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression.
    Shields GE; Wells A; Doherty P; Reeves D; Capobianco L; Heagerty A; Buck D; Davies LM
    BMJ Open; 2020 Sep; 10(9):e035552. PubMed ID: 32912974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: protocol for an economic evaluation alongside the SITLESS three-armed pragmatic randomised controlled trial.
    Deidda M; Coll-Planas L; Giné-Garriga M; Guerra-Balic M; Roqué I Figuls M; Tully MA; Caserotti P; Rothenbacher D; Salvà Casanovas A; Kee F; Blackburn NE; Wilson JJ; Skjødt M; Denkinger M; Wirth K; McIntosh E;
    BMJ Open; 2018 Oct; 8(10):e022266. PubMed ID: 30327403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of frozen shoulder: a systematic review and cost-effectiveness analysis.
    Maund E; Craig D; Suekarran S; Neilson A; Wright K; Brealey S; Dennis L; Goodchild L; Hanchard N; Rangan A; Richardson G; Robertson J; McDaid C
    Health Technol Assess; 2012; 16(11):1-264. PubMed ID: 22405512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone graft substitutes for the treatment of traumatic fractures of the extremities.
    Hagen A; Gorenoi V; Schönermark MP
    GMS Health Technol Assess; 2012; 8():Doc04. PubMed ID: 22984371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-, under- and misuse of pain treatment in Germany.
    Dietl M; Korczak D
    GMS Health Technol Assess; 2011 Apr; 7():Doc03. PubMed ID: 21522485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic analysis of randomized, controlled trials.
    Lyman GH
    Curr Oncol Rep; 2001 Sep; 3(5):396-403. PubMed ID: 11489239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.